Fentanyl Nasal Spray in a Patient With End-Stage COPD and Severe Chronic Breathlessness

Daisy Janssen; Maria van Everdingen - van den Beuken; C.A. Verberkt; Jacques P. H. M. Creemers; Emiel Wouters

doi:10.1183/20734735.0183-2019

Fentanyl Nasal Spray in a Patient With End-Stage COPD and Severe Chronic Breathlessness

Daisy Janssen^*
, Maria van Everdingen - van den Beuken
, C.A. Verberkt
, Jacques P. H. M. Creemers
, Emiel Wouters

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Insufficient control of chronic breathlessness may induce excessive use of fentanyl nasal spray in COPD patients. Prescription of fentanyl nasal spray for breathlessness should only be done as part of palliative treatment and requires close follow-up.

Original language	English
Pages (from-to)	E122-E125
Number of pages	4
Journal	Breathe
Volume	15
Issue number	3
DOIs	https://doi.org/10.1183/20734735.0183-2019
Publication status	Published - 1 Sept 2019

Access to Document

10.1183/20734735.0183-2019Licence: CC BY-NC

Cite this

@article{03cae85fe42e412b8c1ebb3b40eaff6b,

title = "Fentanyl Nasal Spray in a Patient With End-Stage COPD and Severe Chronic Breathlessness",

abstract = "Insufficient control of chronic breathlessness may induce excessive use of fentanyl nasal spray in COPD patients. Prescription of fentanyl nasal spray for breathlessness should only be done as part of palliative treatment and requires close follow-up.",

author = "Daisy Janssen and \{van Everdingen - van den Beuken\}, Maria and C.A. Verberkt and Creemers, \{Jacques P. H. M.\} and Emiel Wouters",

year = "2019",

month = sep,

day = "1",

doi = "10.1183/20734735.0183-2019",

language = "English",

volume = "15",

pages = "E122--E125",

journal = "Breathe",

issn = "1810-6838",

publisher = "European Respiratory Society",

number = "3",

}

TY - JOUR

T1 - Fentanyl Nasal Spray in a Patient With End-Stage COPD and Severe Chronic Breathlessness

AU - Janssen, Daisy

AU - van Everdingen - van den Beuken, Maria

AU - Verberkt, C.A.

AU - Creemers, Jacques P. H. M.

AU - Wouters, Emiel

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Insufficient control of chronic breathlessness may induce excessive use of fentanyl nasal spray in COPD patients. Prescription of fentanyl nasal spray for breathlessness should only be done as part of palliative treatment and requires close follow-up.

AB - Insufficient control of chronic breathlessness may induce excessive use of fentanyl nasal spray in COPD patients. Prescription of fentanyl nasal spray for breathlessness should only be done as part of palliative treatment and requires close follow-up.

U2 - 10.1183/20734735.0183-2019

DO - 10.1183/20734735.0183-2019

M3 - Article

C2 - 31777575

SN - 1810-6838

VL - 15

SP - E122-E125

JO - Breathe

JF - Breathe

IS - 3

ER -

Fentanyl Nasal Spray in a Patient With End-Stage COPD and Severe Chronic Breathlessness

Abstract

Access to Document

Fingerprint

Cite this